Mutations in <it>ASXL1 </it>are associated with poor prognosis across the spectrum of malignant myeloid diseases
<p>Abstract</p> <p>The <it>ASXL1 </it>gene is one of the most frequently mutated genes in malignant myeloid diseases. The ASXL1 protein belongs to protein complexes involved in the epigenetic regulation of gene expression. <it>ASXL1 </it>mutations are found...
Main Authors: | Gelsi-Boyer Véronique, Brecqueville Mandy, Devillier Raynier, Murati Anne, Mozziconacci Marie-Joelle, Birnbaum Daniel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://www.jhoonline.org/content/5/1/12 |
Similar Items
-
ASXL1/2 mutations and myeloid malignancies
by: Edward A. Medina, et al.
Published: (2022-09-01) -
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
by: Rabindranath Bera, et al.
Published: (2019-10-01) -
ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype
by: Concepción Prats‐Martín, et al.
Published: (2020-06-01) -
Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
by: Yi Fan, et al.
Published: (2021-10-01) -
Acute myeloid leukemia in a father and son with a germline mutation of ASXL1
by: Karen Seiter, et al.
Published: (2018-02-01)